IL15 and neoplasm: To test whether this enhanced IL-15 signaling led to enhanced function, we incubated pbNK cells or eNK cells with the SS1 TriKE or an equifunctional dose of IL-15 for 7 days in severe hypoxia, in the absence of any tumor target.